Reduction of HbA1c in patients with type 2 diabetes following duodenal mucosal resurfacing: could other factors be at play?

Michael P Johnston¹, Ryan Malcolm Buchanan^{2

3}, Janisha Patel², Nadeem Tehami²

Affiliations

¹ Department of Hepatology, University Hospital Southampton NHS Foundation Trust, Southampton, Southampton, UK michael.johnston1@nhs.net.
² Department of Hepatology, University Hospital Southampton NHS Foundation Trust, Southampton, Southampton, UK.
³ Department of Primary Care and Population Sciences, University of Southampton, Southampton, UK.

PMID: 32102927
DOI: 10.1136/gutjnl-2020-320900

Comment

Reduction of HbA1c in patients with type 2 diabetes following duodenal mucosal resurfacing: could other factors be at play?

Michael P Johnston et al. Gut. 2020 Dec.

. 2020 Dec;69(12):2260-2261.

doi: 10.1136/gutjnl-2020-320900. Epub 2020 Feb 26.

Authors

Michael P Johnston¹, Ryan Malcolm Buchanan^{2

3}, Janisha Patel², Nadeem Tehami²

Affiliations

¹ Department of Hepatology, University Hospital Southampton NHS Foundation Trust, Southampton, Southampton, UK michael.johnston1@nhs.net.
² Department of Hepatology, University Hospital Southampton NHS Foundation Trust, Southampton, Southampton, UK.
³ Department of Primary Care and Population Sciences, University of Southampton, Southampton, UK.

PMID: 32102927
DOI: 10.1136/gutjnl-2020-320900

No abstract available

Keywords: diabetes mellitus; duodenal mucosa; endoscopic procedures.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Comment in

Response to letter titled 'Reduction of HbA1c in patients with type 2 diabetes following duodenal mucosal resurfacing: could other factors be at play?'.
Bergman J. Bergman J. Gut. 2021 Jan;70(1):218. doi: 10.1136/gutjnl-2020-321170. Epub 2020 Mar 30. Gut. 2021. PMID: 32229545 Free PMC article. No abstract available.

Comment on

Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study.
van Baar ACG, Holleman F, Crenier L, Haidry R, Magee C, Hopkins D, Rodriguez Grunert L, Galvao Neto M, Vignolo P, Hayee B, Mertens A, Bisschops R, Tijssen J, Nieuwdorp M, Guidone C, Costamagna G, Devière J, Bergman JJGHM. van Baar ACG, et al. Gut. 2020 Feb;69(2):295-303. doi: 10.1136/gutjnl-2019-318349. Epub 2019 Jul 22. Gut. 2020. PMID: 31331994 Free PMC article. Clinical Trial.

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

Grants and funding

DH_/Department of Health/United Kingdom

LinkOut - more resources

Full Text Sources
- HighWire
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Reduction of HbA1c in patients with type 2 diabetes following duodenal mucosal resurfacing: could other factors be at play?

Affiliations

Reduction of HbA1c in patients with type 2 diabetes following duodenal mucosal resurfacing: could other factors be at play?

Authors

Affiliations

Conflict of interest statement

Comment in

Comment on

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources

Full Text Sources

Medical